Login
Azitra, Inc. logo

Azitra, Inc.

azitrainc.com

Azitra Inc (AZTR) is a clinical-stage biopharmaceutical company. The filing excerpts provided do not contain sufficient detail to describe its core business activity, revenue model, competitive position, or financial metrics with the specificity required. The excerpts consist solely of boilerplate SEC cover-page language and do not disclose product names, pipeline assets, revenue figures, customer information, geographic footprint, leadership, or founding history. No defensible business description can be constructed from the available filing content.

Financial Snapshot

Revenue
Last 4 Quarters
N/A
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$12.27M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
486.3%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$7.334M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$11.17M

Stock Price

Loading...
Market Cap: $10.878 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support